Loading…
Biohaven Ltd. is projected to rise to $17.24 by 2027, a +25% move from its current price of $13.82. BHVN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $13.32 | $13.83 | $14.36 | +0.08% |
| Aug 2 | $13.12 | $13.84 | $14.60 | +0.15% |
| Aug 3 | $12.98 | $13.85 | $14.78 | +0.23% |
| Aug 4 | $12.86 | $13.86 | $14.95 | +0.31% |
| Aug 5 | $12.75 | $13.87 | $15.09 | +0.39% |
| Aug 6 | $12.66 | $13.88 | $15.22 | +0.46% |
| Aug 7 | $12.58 | $13.89 | $15.35 | +0.54% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.58 | $13.89 | $15.35 | +0.54% |
| Week 2 | $12.14 | $13.97 | $16.08 | +1.08% |
| Week 3 | $11.82 | $14.05 | $16.69 | +1.63% |
| Week 4 | $11.57 | $14.12 | $17.23 | +2.18% |
| Week 5 | $11.36 | $14.20 | $17.74 | +2.73% |
| Week 6 | $11.19 | $14.27 | $18.21 | +3.29% |
| Week 7 | $11.03 | $14.35 | $18.67 | +3.84% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Biohaven Ltd. is a biopharmaceutical company focused on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology worldwide. Its pipeline includes BHV-1300 (Phase 2 for Graves’ disease and rheumatoid arthritis), BHV-1400 (Phase 2 for IgA nephropathy), BHV-1600 (Phase 1 for peripartum cardiomyopathy), BHV-8000 (Phase 3 for Parkinson’s disease), and Opakalim (Phase 3 for focal epilepsy).
It also lists BHV-2100 (Phase 2 for pain disorders), BHV-2000 (Phase 2 for obesity), BHV-1510 (Phase 2 for advanced or metastatic epithelial tumors), and BHV-1530 (Phase 2 for urothelial cancer and other tumors). In addition, its preclinical pipeline includes BHV-1310, BHV-1320, BHV-1450, BHV-1420, BHV-1440, BHV-6500, BHV-1490, BHV-8100, and BHV-1955. The company was formerly Biohaven Research Ltd.
and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
Biohaven Ltd. trades under the symbol BHVN and has a current price of $13.77 with a market capitalization of $2.07B, ranking 1936 by market cap. The price outlook combines a bullish longer-term forecast with a steady near-term path, as reflected in the year-by-year averages shown in its forecast table.
The 2026 average price aligns with the current level at $13.77, with a trajectory toward higher prices in the years that follow.
A major floor 41.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.8% away) — a key level to hold.
The nearest ceiling, 21.5% above — a clean break opens room to run.
A major ceiling 30.5% above — clearing it would confirm fresh momentum.
Key BHVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BHVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $13.97 | Sell | $13.97 | Sell |
| MA 10 | $14.51 | Sell | $14.31 | Sell |
| MA 20 | $15.04 | Sell | $14.47 | Sell |
| MA 50 | $13.27 | Buy | $13.53 | Buy |
| MA 100 | $11.40 | Buy | $12.56 | Buy |
| MA 200 | $11.59 | Buy | $13.22 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.20 | Neutral |
| Stoch RSI (14) | 21.73 | Neutral |
| CCI (20) | -110.73 | Sell |
| Williams %R (14) | -81.25 | Info |
| MACD (12,26,9) | -0.33 | Sell |
| ROC (12) | -7.50 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 18.75 | Buy |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | -0.64 | Sell |
| Ultimate (7,14,28) | 29.50 | Buy |
| Momentum (10) | -0.35 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 13.47 | Buy |
| ADX (14) | 16.13 | Neutral |
| ATR (14) | 0.50 | Info |
Technical picture for the last 30 days shows a price range from $10.65 to $17.80. The RSI on 14 periods is 50, with the 50-day moving average at $12.97 and the 200-day moving average at $11.63. Key near-term support sits at $11.28 and resistance at $16.79. These levels imply a modestly constructive setup within a defined trading corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.09 | $13.82 | $20.49 | 0% | Neutral | |
| $13.27 | $17.24 | $23.93 | +25% | Bullish | |
| $16.21 | $21.93 | $31.98 | +59% | Bullish | |
| $20.38 | $28.51 | $43.18 | +106% | Bullish | |
| $22.41 | $32.31 | $50.50 | +134% | Bullish | |
| $23.38 | $34.66 | $55.67 | +151% | Bullish | |
| $22.37 | $34.02 | $56.00 | +146% | Bullish | |
| $24.29 | $37.86 | $63.70 | +174% | Bullish | |
| $29.86 | $47.65 | $81.78 | +245% | Bullish | |
| $35.14 | $57.36 | $100.29 | +315% | Bullish | |
| $42.05 | $76.25 | $143.96 | +452% | Bullish | |
| $76.93 | $168.89 | $355.92 | +11.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.09 | $13.82 | $16.14 | +0.00% |
| August 2026 | $11.83 | $14.00 | $17.03 | +1.28% |
| September 2026 | $12.39 | $14.82 | $18.37 | +5.92% |
| October 2026 | $12.41 | $14.99 | $18.84 | +1.15% |
| November 2026 | $12.34 | $15.02 | $19.10 | +0.20% |
| December 2026 | $13.01 | $15.95 | $20.49 | +6.18% |
Click any year to see its month-by-month BHVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BHVN price prediction for 2026 points to an average of $13.82 (low $8.09, high $20.49) — a potential gain of 0% on today's $13.82. A consolidation phase looks the most probable path here.
In 2027, BHVN is projected to trade between $13.27 and $23.93, averaging $17.24 — a potential gain of +25% from today's $13.82. That is up +25% on the projected 2026 average. Momentum favours further upside here.
Biohaven Ltd.'s 2028 outlook centres on $21.93, within a $16.21 to $31.98 range. That is up +27% on the projected 2027 average. That marks a +59% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, BHVN could reach as high as $43.18, with a base case around $28.51 and support toward $20.38 — roughly +106% from $13.82. Momentum favours further upside here.
Expect BHVN to range from $22.41 to $50.50 through 2030. The $32.31 average target implies a +134% move from current prices. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The BHVN price prediction for 2031 points to an average of $34.66 (low $23.38, high $55.67) — a potential gain of +151% on today's $13.82. Momentum favours further upside here.
In 2032, BHVN is projected to trade between $22.37 and $56.00, averaging $34.02 — a potential gain of +146% from today's $13.82. That is -2% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Biohaven Ltd.'s 2033 outlook centres on $37.86, within a $24.29 to $63.70 range. That is up +11% on the projected 2032 average. That marks a +174% change versus current levels. Momentum favours further upside here.
By 2034, BHVN could reach as high as $81.78, with a base case around $47.65 and support toward $29.86 — roughly +245% from $13.82. Buyers look set to stay in control over this stretch.
Expect BHVN to range from $35.14 to $100.29 through 2035. The $57.36 average target implies a +315% move from current prices. That is up +20% on the projected 2034 average. Momentum favours further upside here.
The BHVN price prediction for 2040 points to an average of $76.25 (low $42.05, high $143.96) — a potential gain of +452% on today's $13.82. Buyers look set to stay in control over this stretch.
In 2050, BHVN is projected to trade between $76.93 and $355.92, averaging $168.89 — a potential gain of +11.2x from today's $13.82. That is up +122% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BHVN today (≈ 72.3589 BHVN) could be worth
$12,220.66
+$11,220.66 (+1122%) by 2050 · US Dollar
Based on the average projected BHVN price of $168.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BHVNwould be worth at today's price.
$1,000 invested in BHVN on Jul 30, 2025 (≈ 64.102563 BHVN) would be worth
$885.9
-$114.1 (-11.4%) today · 0.89× · US Dollar
Based on a BHVN entry price of $15.6 vs. today's $13.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14.65 | $943.34 | -5.7% |
| 1 month ago | $14.88 | $928.76 | -7.1% |
| 3 months ago | $9.63 | $1,435.1 | +43.5% |
| 6 months ago | $11.83 | $1,168.22 | +16.8% |
| 1 year ago | $15.6 | $885.9 | -11.4% |
| All time (3.9y) ago | $7.14 | $1,936.69 | +93.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BHVN forecast.
Our base-case forecast reaches $28.00 around 2029.
Implied market cap at $28.00: $4.22B
The multi-year forecast points to a strong longer-run upside, with the average price rising from $13.77 in 2026 to $32.86 by 2030 (ROI 138.7%), and continuing higher to $78.86 by 2040 (ROI 472.7%) and $175.93 by 2050 (ROI 1177.7%). The path includes 2027 ($17.25 avg, ROI 25.3%), 2028 ($22.18 avg, ROI 61.1%), and 2029 ($29.14 avg, ROI 111.6%). By 2031–2035 the forecast shows continued gains, with 2035 at $59.28 avg and a max around $104.89.
While these figures suggest meaningful upside, they are estimates and not guarantees, and outcomes depend on a range of market and clinical development factors.
Tap a question to reveal the answer.
Avg $32.86; min $22.59; max $51.85; ROI 138.7%.
The forecast shows bullish sentiment from 2027 onward with averages rising to $175.93 by 2050 and a max of $376.70, but these are estimates and not guarantees.
Yes—the forecast shows a max of $104.89 in 2035, $150.95 in 2040, and $376.70 in 2050.
Current price $13.77; market cap $2.07B.
Low $10.65; High $17.80.
Biohaven Ltd. Community Discussion
0Share your Biohaven Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.